Feb 28,2023

Aravive Announces FDA Orphan Drug Designation Granted to Batiraxcept for the Treatment of Pancreatic Cancer

Feb 14,2023

Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin

Feb 10,2023

Cognition Therapeutics Completes Enrollment of CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease

Feb 08,2023

Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios

Jan 31,2023

C4 Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating CFT1946, an Orally Bioavailable BiDAC™ Degrader, in BRAF V600 Mutant Solid Tumors

Jan 27,2023

Twist Bioscience Begins Shipping Commercial Product from Synthetic DNA Manufacturing Factory of the Future

Jan 10,2023

Twist and Astellas Partner on Antibody Discovery Program

Jan 05,2023

Immune-Onc Therapeutics Announces Close of Series B Extension Financing, Bringing Total Round to $131 Million

End of content

No more pages to load

Next page